Dersimelagon in Erythropoietic Protoporphyrias. Reply. | N Engl J Med;388(26): 2492-2493, 2023 Jun 29. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Dersimelagon in Erythropoietic Protoporphyrias. Reply.

Balwani, Manisha; Desnick, Robert J; Belongie, Kirstine.

Affiliation

Balwani M; Icahn School of Medicine at Mount Sinai, New York, NY.
Desnick RJ; Icahn School of Medicine at Mount Sinai, New York, NY.
Belongie K; Mitsubishi Tanabe Pharma America, Jersey City, NJ kirstine_belongie@mt-pharma-us.com.

N Engl J Med ; 388(26): 2492-2493, 2023 Jun 29.

Article in En | MEDLINE | ID: mdl-37379151

Subject(s)

Protoporphyria, Erythropoietic; Humans; Protoporphyria, Erythropoietic/diagnosis; Protoporphyria, Erythropoietic/genetics

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protoporphyria, Erythropoietic Type of study: Diagnostic_studies Limits: Humans Language: En Journal: N Engl J Med Year: 2023 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protoporphyria, Erythropoietic Type of study: Diagnostic_studies Limits: Humans Language: En Journal: N Engl J Med Year: 2023 Type: Article